CD101: A New Long-Acting Echinocandin
David Andes, MD, shares the half-life and dosing intervals for a new long-acting echinocandin.
David Andes, MD, professor and chief of infectious disease at the University of Wisconsin, shares the half-life and dosing intervals for a new long-acting echinocandin.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Recent Videos
Related Content
